Charles G. Lineberry
Gründer bei Lineberry Research Associates LLC
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| John Didsbury | M | 68 |
T3D Therapeutics, Inc.
 T3D Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology T3D Therapeutics, Inc. engages in the development of its drug product candidate, T3D-959, to treat Alzheimer's disease. The company was founded in 2013 and is headquartered in Research Triangle Park, NC. | - |
| Cathy Frieden Lineberry | F | - |
Lineberry Research Associates LLC
 Lineberry Research Associates LLC Miscellaneous Commercial ServicesCommercial Services Lineberry Research Associates LLC operates as a contract research and consulting company, offers drug research, development, and marketing services to pharmaceutical and biotechnology companies. Its services include strategic consulting, clinical research and regulatory affairs, scientific writing and communications. The company was founded in July 1995 by Cathy Frieden Lineberry and is headquartered in Research Triangle Park, NC. | - |
| J. Barry Buzogany | M | - |
T3D Therapeutics, Inc.
T3D Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology T3D Therapeutics, Inc. engages in the development of its drug product candidate, T3D-959, to treat Alzheimer's disease. The company was founded in 2013 and is headquartered in Research Triangle Park, NC. | 11 Jahre |
| John A. Golden | M | 79 |
T3D Therapeutics, Inc.
T3D Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology T3D Therapeutics, Inc. engages in the development of its drug product candidate, T3D-959, to treat Alzheimer's disease. The company was founded in 2013 and is headquartered in Research Triangle Park, NC. | - |
| Thomas G. Mendell | M | - |
T3D Therapeutics, Inc.
T3D Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology T3D Therapeutics, Inc. engages in the development of its drug product candidate, T3D-959, to treat Alzheimer's disease. The company was founded in 2013 and is headquartered in Research Triangle Park, NC. | 8 Jahre |
| David B. Keim | M | - |
T3D Therapeutics, Inc.
T3D Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology T3D Therapeutics, Inc. engages in the development of its drug product candidate, T3D-959, to treat Alzheimer's disease. The company was founded in 2013 and is headquartered in Research Triangle Park, NC. | 5 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 6 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Charles G. Lineberry
- Persönliches Netzwerk
